Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 18 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (3)
Early P 1 (1)
P 1 (4)
P 2 (3)
P 3 (2)

Trial Status

Recruiting9
Completed3
Active Not Recruiting2
Not Yet Recruiting2
Withdrawn2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT06903065Phase 1Active Not RecruitingPrimary

A Study to Assess the Safety, Pharmacokinetics, and Activity of RO7790121 in Participants With Advanced MASH Liver Fibrosis

NCT07763015Phase 2RecruitingPrimary

Study of Resmetirom in Children and Adolescents With MASH

NCT07512427Phase 1RecruitingPrimary

Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants

NCT07051863Recruiting

Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease

NCT06138821Not ApplicableRecruiting

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

NCT06940375Completed

Incidence of Liver Disease-Related Outcomes in People With HIV

NCT06588699Phase 2Recruiting

Digoxin In NASH (CODIN)

NCT07083557Recruiting

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

NCT06485245Phase 1Active Not RecruitingPrimary

Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects

NCT07417683Not ApplicableNot Yet Recruiting

Multicentric Approval Study Trans-Duodenal Barrier for Typ 2 Diabetes With Obesity

NCT06592820Recruiting

Endoscopic Ultrasound Shear Wave Elastography Study

NCT06573528Phase 1CompletedPrimary

Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060380 in Healthy and Elevated LDL-C Subjects

NCT06692283Phase 3Withdrawn

A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH

NCT06594523Phase 3WithdrawnPrimary

A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis

NCT06342947Phase 2Completed

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

NCT06562361Early Phase 1RecruitingPrimary

A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups.

NCT05651724RecruitingPrimary

Global Research Initiative for Patients Screening on MASH

NCT06446908Not ApplicableNot Yet Recruiting

Acceptability and Feasibility of a New Approach to Engage Patients With Steatotic Liver Disease in Physical Activity

Showing all 18 trials

Research Network

Activity Timeline